Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 09-2019 | 06-2019 | |
| Operating Expenses | 0 | 21,908 | 19,905 |
| Operating Income | N/A | -21,908 | -19,905 |
| Other Income | 0 | 2,235 | 2,368 |
| Pre-tax Income | 0 | -19,673 | -17,537 |
| Net Income Continuous | N/A | -19,673 | -17,537 |
| Net Income | $N/A | $-19,673 | $-17,537 |
| EPS Basic Total Ops | N/A | -5.53 | -5.28 |
| EPS Basic Continuous Ops | N/A | -5.53 | -5.28 |
| EPS Diluted Total Ops | N/A | -5.53 | -5.28 |
| EPS Diluted Continuous Ops | N/A | -5.53 | -5.28 |
| EBITDA(a) | $N/A | $-22,412 | $-19,905 |